BioWavePENS is a percutaneous frequency conduction pain block – the only FDA-cleared PENS device indicated for treating chronic, acute and post-operative pain. BioWavePENS is comprised of a BioWavePRO high-frequency neurostimulator and BioWave Percutaneous Electrodes. BioWave Percutaneous Electrodes are an array of over 1,000 needles 0.74mm in length that are inserted through the epidermis to provide a direct conductive pathway through skin allowing for deeper penetration of the active electrical field. BioWavePENS is the most advanced nerve stimulation therapy for treating severe chronic, acute or post-operative pain. It’s currently used to treat both nociceptive and neuropathic pain, typically in a pain and spine clinic or hospital setting under the supervision of a physician.
The Percutaneous Electrode facilitates the delivery of a summation of high-frequency electrical signals through skin directly to the surface of nociceptive pain fibers.
The polarization of the pain fibers cause a multiplication of the high-frequency signals resulting in a low-frequency active electrical field encompassing the pain site. The active electrical field is thought to hyperpolarize the nerve and prevent the sodium-potassium ion exchange across the membrane of the C-fiber, inhibiting transmission of the pain signal (Frequency Conduction Block Theory). The electrical field also induces hypoesthesia in the volume of tissue treated beneath and surrounding each electrode.
BioWaveHOME is a prescription neurostimulator for patients to treat chronic, acute and post-operative musculoskeletal pain on an as-needed basis at home or while traveling.
If patients respond to BioWavePENS in the physician’s office, they typically will also respond to BioWaveHOME with noninvasive, reusable electrodes at home.
Download BiowavePENS Brochures